Arcadia Biosciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -47.1% | -47.1% | -33.4% |
| FY2022 | -73.1% | -73.1% | -53.2% |
| FY2023 | -108.9% | -108.9% | -71.0% |
| FY2024 | -113.1% | -113.1% | -52.1% |
| FY2025 | -56.5% | -56.5% | -35.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -47.1% | -47.1% | -33.4% |
| FY2022 | -73.1% | -73.1% | -53.2% |
| FY2023 | -108.9% | -108.9% | -71.0% |
| FY2024 | -113.1% | -113.1% | -52.1% |
| FY2025 | -56.5% | -56.5% | -35.7% |